ACADIA Pharmaceuticals (ACAD)- Glenn Baity, EVP and GC, sold 16,000 shares in two separate transactions. Baity sold 11,943 shares at $35 and 4,057 shares also at $35. Baity still owns 62,921 shares of ACAD.
Xencor (XNCR)- Edgardo Baracchini Jr., Chief Business Officer, sold 1,250 shares at $18.13. The total value of the transaction was $22,663. Baracchini still owns 4,528 shares of XNCR.
Eli Lilly (LLY)- Lilly Endowment Inc., a 10% owner, sold 210,000 shares at $79.54. The total value of the transaction was approximately $16.70 million. Lilly Endowment still owns 126,220,804 shares of LLY.
Epizyme (EPZM)- Andrew E. Singer, EVP & CFO, sold 1,013 shares at $10.36. The total value of the transaction was $10,494. Singer still owns 24,592 shares of EPZM.